Home Biosimilar Antibodies Metabolism PCSK9 antibody Tafolecimab (Anti-PCSK9) For research use only.
Not for use in humans.

Tafolecimab (Anti-PCSK9)

Synonyms: IBI-306

Tafolecimab (Anti-PCSK9) is a human lgG2 monoclonal antibody that specifically targets PCSK-9. It may be used in studies of hypercholesterolaemia. MW :145.34 KD.

Tafolecimab (Anti-PCSK9)

Purity & Quality Control

≥99

Choose Selective PCSK9 Inhibitors

Biological Activity

Description Tafolecimab (Anti-PCSK9) is a human lgG2 monoclonal antibody that specifically targets PCSK-9. It may be used in studies of hypercholesterolaemia. MW :145.34 KD.

Product Details

CAS No. 2225109-03-3
Isotype Human IgG2SA
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tafolecimab (Anti-PCSK9) | Tafolecimab (Anti-PCSK9) supplier | purchase Tafolecimab (Anti-PCSK9) | Tafolecimab (Anti-PCSK9) cost | Tafolecimab (Anti-PCSK9) manufacturer | order Tafolecimab (Anti-PCSK9) | Tafolecimab (Anti-PCSK9) distributor